| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUUCCUUGGCUCAGUGCCCUUCACCACUGCUGGCUUUUUGCUGUAGCUC… | 485 nt | 0.4619 |
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein is proposed to be involved in specific calcium-dependent signal transduction pathways and its regulatory effect on cytoskeletal components may modulate various neutrophil activities. The protein includes an antimicrobial peptide which has antibacterial activity. [provided by RefSeq, Nov 2014]
A study in humans identified the S100A12 as a significantly upregulated immune-related gene in acute myocardial infarction (AMI) patients compared to coronary heart disease controls, with its expression highest in neutrophils and decreasing from day 1 to one month post-AMI, demonstrating an area under the curve (AUC) of 0.798 for discriminating AMI [Liu et al. DOI:10.1042/BSR20222552]. Another study in humans found the S100A12 to be significantly upregulated in infective endocarditis and sepsis samples, where it plays a crucial role in immune and inflammatory responses and demonstrates excellent diagnostic performance with an AUC greater than 0.781 [Chen et al. DOI:10.3389/fimmu.2023.1298041]. A study in human traumatic brain injury (TBI) patients demonstrated that S100 calcium binding protein A12 (S100A12) mRNA was one of the five most significantly up-regulated mRNAs in TBI tissue compared to adjacent control tissue, a finding confirmed by quantitative real-time polymerase chain reaction [Yang et al. DOI:10.4103/1673-5374.247467].